ONO. V. Nezdorovin

O. V. Nezdorovin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


O. V. Nezdorovin has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Spinal cord injury: a modern view on pathophysiology and phylogeny

    by A. Z. Gagiev, A. V. Kudziev, O. V. Nezdorovin, N. A. Lesteva, M. V. Aleksandrov, E. N. Zharova, D. A. Sitovskaya, A. A. Oleinik, M. A. Naumov, K. B. Abramov, et al.

    Traumatic injury to the spinal cord causes serious damage to the central nervous system and inevitably leads to disruption of neural connections and the development of persistent neurological deficits. After a spinal cord injury, there is a spontaneous recovery mechanism, but it faces many difficulties, and external intervention is required to further improve the ability to recover. Understanding the mechanisms underlying spinal cord development and pathophysiological processes during its damage can provide important information for the development of treatment methods and the search for targets to activate regenerative potential. Current knowledge in this area should be evaluated in order to develop appropriate treatment methods aimed at improving recovery from spinal cord injury. The review contains the current views of the authors on the above processes. The purpose of this review is to analyze and systematize data on the pathophysiology of spinal cord injury, intermolecular and intercellular interactions, and its development processes for a more detailed understanding of the regenerative potential of the spinal cord.

  • Open Access

    The social and demographics characteristics of neurosurgical patients with drug-resistant temporal lobe epilepsy

    by Н. О. Деньгина, N. E. Ivanova, K. A. Samochernikh, K. B. Abramov, V. G. Nezdorovina, O. G. Nezdorovin, T. A. Salomatina, G. V. Odintsova, M. V. Dikonenko

    THE PURPOSE OF THE STUDY is to analyze the social and demographic characteristics of neurosurgical patients with drug-resistant epilepsy.MATERIALS AND METHODS. A non-randomised, retrospective parallel group study was conducted at Polenov Neurosurgical Institute, a branch of Almazov National Research Centre.THE OBJECT OF THE STUDY was neurosurgical patients with drug-resistant epilepsy. The subject of the study was social and demographic indicators.The study involved 100 patients diagnosed with pharmacoresistant temporal lobe epilepsy and treated at the DeparTment of Functional Neurosurgery No. 2 of Polenov Neurosurgical Institute in 2022.Patients were divided into 2 groups depending on the type of surgical procedure: Group 1 — those who underwent resective surgery, and Group 2 — destructive surgery. Social, demographic and clinical data were examined in both groups and the cohort. Social functioning was assessed by education, employment and disability status.RESULTS. Group 1 consisted of 78 patients; group 2 included 22 patients. Patients ranged in age from 19 to 54 years, with an average age of 32.3±8.18 years. males outnumbered females, 53 % and 47 % respectively. The mean duration of epilepsy in the cohort was 20.09±9.24 years, with no difference between groups. The level of education in the cohort was characterised by a preponderance of vocational education at 42 % compared to general secondary education at 24 % and tertiary education at 34 %. There were twice as many unemployed as employed people in the cohort — 63.9 % and 30.6 %. The number of patients with disabilities was 59 %, with patients with disabilities predominating in Group 1 and patients without disabilities in Group 2.CONCLUSION. There were no significant differences in social functioning between the groups, as there was no difference in the duration of the disease before treatment. Long-term disease progression has a negative impact on social functioning in people with epilepsy. The neurosurgical cohort with drug-resistant epilepsy is characterised by problems of social adjustment: Two-thirds were disabled and unemployed, and a quarter of patients had only a school leaving certificate and no qualifications. There is a need to actively inform physicians and patients about existing surgical management options for epilepsy in order to increase the use of modern epilepsy neurosurgery.


  • An impact of COVID-19 on the course of epilepsy

    by G.V. Odincova, O.V. Nezdorovin, V.G. Nezdorovina

    Представлен сравнительный анализ двух клинических случаев влияния на динамику эпилепсии заболевания COVID-19 и иммунизации вакциной «Спутник V». Работа является частью проводимого инициативного исследования «Эпилепсия и COVID-19» с набором пациентов с эпилепсией в две группы: перенесшие COVID-19 и иммунизированные вакциной против COVID-19. В статье представлен сравнительный анализ двух клинических случаев: рецидива приступов при заболевании COVID-19 у пациента молодого возраста и хорошей переносимости вакцинации пациенткой старшего возраста с коморбидной патологией после хирургического лечения фармакорезистентной эпилепсии. У пациента К. 32 лет с генерализованной генетической (идиопатической) эпилепсией и ремиссией приступов в течение 3 лет на фоне легкой формы COVID-19 развился рецидив генерализованных тонико-клонических приступов с ухудшением электроэнцефалографических показателей. У пациентки Ф. 59 лет с фокальной фармакорезистентной эпилепсией и ремиссией приступов в течение 3 лет после хирургического лечения, с коморбидной эндокринной патологией при вакцинации «Спутник V» не отмечалось побочных явлений и сохранялась клинико-электроэнцефалографическая ремиссия. Результаты исследования показали хорошую переносимость вакцины «Спутник V» с сохранением ремиссии приступов после нейрохирургического лечения фармакорезистентной эпилепсии у пациентки старшего возраста с коморбидной патологией и возможность рецидива приступов у пациентов молодого возраста на фоне легкого течения COVID-19. Полученные результаты помогут практическим врачам определиться с тактикой ведения пациентов с эпилепсией. Необходимо дальнейшее продолжение исследований по влиянию заболевания и вакцинации против COVID-19 на динамику эпилепсии в большей выборке.